Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study.

Lindh I, Milsom I.

Hum Reprod. 2013 Jul;28(7):1953-60. doi: 10.1093/humrep/det101. Epub 2013 Apr 11.

PMID:
23578948
[PubMed - indexed for MEDLINE]
Free Article
2.

Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.

Kelekci S, Kelekci KH, Yilmaz B.

Contraception. 2012 Nov;86(5):458-63. doi: 10.1016/j.contraception.2012.04.001. Epub 2012 Jul 24.

PMID:
22832203
[PubMed - indexed for MEDLINE]
3.

Uterine perforation caused by intrauterine devices: clinical course and treatment.

Kaislasuo J, Suhonen S, Gissler M, Lähteenmäki P, Heikinheimo O.

Hum Reprod. 2013 Jun;28(6):1546-51. doi: 10.1093/humrep/det074. Epub 2013 Mar 22.

PMID:
23526304
[PubMed - indexed for MEDLINE]
Free Article
4.

The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.

Sheng J, Zhang WY, Zhang JP, Lu D.

Contraception. 2009 Mar;79(3):189-93. doi: 10.1016/j.contraception.2008.11.004. Epub 2008 Dec 11.

PMID:
19185671
[PubMed - indexed for MEDLINE]
5.

Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.

Kaislasuo J, Suhonen S, Gissler M, Lähteenmäki P, Heikinheimo O.

Hum Reprod. 2012 Sep;27(9):2658-63. doi: 10.1093/humrep/des246. Epub 2012 Jul 3.

PMID:
22763376
[PubMed - indexed for MEDLINE]
Free Article
6.

Intrauterine devices: an effective alternative to oral hormonal contraception.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):125-30.

PMID:
19637436
[PubMed - indexed for MEDLINE]
7.

Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Helmerhorst F, Guillebaud J.

Cochrane Database Syst Rev. 2004;(3):CD001776. Review.

PMID:
15266453
[PubMed - indexed for MEDLINE]
8.

Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices.

Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E, Elaut E, Amy JJ.

J Sex Med. 2012 Apr;9(4):1065-73. doi: 10.1111/j.1743-6109.2011.02266.x. Epub 2011 Apr 14.

PMID:
21492401
[PubMed - indexed for MEDLINE]
9.

Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.

Heikinheimo O, Inki P, Schmelter T, Gemzell-Danielsson K.

Hum Reprod. 2014 Jun;29(6):1182-8. doi: 10.1093/humrep/deu063. Epub 2014 Mar 28.

PMID:
24682613
[PubMed - in process]
Free PMC Article
10.
11.

The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study.

Lindh I, Ellström AA, Milsom I.

Hum Reprod. 2012 Mar;27(3):676-82. doi: 10.1093/humrep/der417. Epub 2012 Jan 17.

PMID:
22252090
[PubMed - indexed for MEDLINE]
Free Article
12.

Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.

Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A.

Hum Reprod. 2014 Oct 10;29(10):2163-70. doi: 10.1093/humrep/deu191. Epub 2014 Aug 1.

PMID:
25085802
[PubMed - in process]
13.

A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Sturridge F, Guillebaud J.

Drug Saf. 1996 Dec;15(6):430-40. Review.

PMID:
8968696
[PubMed - indexed for MEDLINE]
14.

Selection and performance of the levonorgestrel-releasing intrauterine system.

Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J.

Acta Obstet Gynecol Scand Suppl. 1997;164:69-74.

PMID:
9225643
[PubMed - indexed for MEDLINE]
15.

Intrauterine devices. The optimal long-term contraceptive method?

Fortney JA, Feldblum PJ, Raymond EG.

J Reprod Med. 1999 Mar;44(3):269-74. Review.

PMID:
10202746
[PubMed - indexed for MEDLINE]
16.

[Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].

Gardyszewska A, Czajkowski K.

Ginekol Pol. 2012 Dec;83(12):950-2. Polish.

PMID:
23488301
[PubMed - indexed for MEDLINE]
17.

[The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].

Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.

Minerva Ginecol. 2002 Jun;54(3):271-8. Italian.

PMID:
12063443
[PubMed - indexed for MEDLINE]
18.

Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Guillebaud J.

Cochrane Database Syst Rev. 2001;(2):CD001776. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD001776.

PMID:
11406007
[PubMed - indexed for MEDLINE]
19.

Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.

Wildemeersch D, Jandi S, Pett A, Nolte K, Hasskamp T, Vrijens M.

Int J Womens Health. 2014 Aug 6;6:727-34. doi: 10.2147/IJWH.S65462. eCollection 2014.

PMID:
25125987
[PubMed]
Free PMC Article
20.

Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.

Luukkainen T, Toivonen J.

Contraception. 1995 Nov;52(5):269-76. Review.

PMID:
8585882
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk